Home

Brett L Scott

CIK 1405195 · Acting Chief Financial Officer · last filed 2019-07-24

Brett L Scott is an Acting Chief Financial Officer who has filed 10 SEC Form 4 insider transactions across 4 companies since 2008. The most recent filing, for DSS, was dated Jul 24, 2019. Across all open-market trades the lifetime net is −$47.8K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $37 across reported positions. 7 SEC filings were submitted jointly with SPECTRUM PHARMACEUTICALS INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$37

Companies

4

Total Filings

10

Lifetime Open-Market Net

-$47.8K

Filer Profile

Reported Address
15770 LAGUNA CANYON ROAD
SUITE 150
IRVINE, CA 92618
Related Filers
SPECTRUM PHARMACEUTICALS INC — 7 joint filings, latest 2012-10-02
DSS, INC. — 2 joint filings, latest 2019-07-24
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
DSS Director 51 $0.72 $37 $0 1 2019-07-24
SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted Acting Chief Financial Officer 45,661 $1.03 $47.0K -$47.8K 6 2012-10-02
BIOLASE, INC (BLTI) Delisted Chief Financial Officer — — — $0 1 2009-07-14
NORTH AMERICAN SCIENTIFIC INC (NASM) Delisted CHIEF FINANCIAL OFFICER — — — $0 1 2008-08-12

Recent Filings

10 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2019-07-24 DSS Grant (A) +30,575 $0 EDGAR
2012-10-02 SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted Sell (S) −6,000 -$72.0K EDGAR
2012-09-10 SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted Grant (A) — $0 EDGAR
2011-12-23 SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted Mixed +46,321 $684.2K EDGAR
2011-06-14 SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted Grant (A) — $0 EDGAR
2011-01-21 SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted Buy (P) +4,000 $24.2K EDGAR
2010-10-12 SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted Grant (A) — $0 EDGAR
2009-07-14 BIOLASE, INC (BLTI) Delisted Grant (A) — $0 EDGAR
2008-08-12 NORTH AMERICAN SCIENTIFIC INC (NASM) Delisted Grant (A) — $0 EDGAR
2007-07-05 — Grant (A) — $0
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.